STAPHYLOCOCCUS AUREUS ENDOCARDITIS
Clinical trials for STAPHYLOCOCCUS AUREUS ENDOCARDITIS explained in plain language.
Never miss a new study
Get alerted when new STAPHYLOCOCCUS AUREUS ENDOCARDITIS trials appear
Sign up with your email to follow new studies for STAPHYLOCOCCUS AUREUS ENDOCARDITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Head-to-Head antibiotic showdown for dangerous blood infections
Disease control Recruiting nowThis study aims to find out which of two common antibiotics works better for treating serious MRSA bloodstream infections. It will enroll 300 patients and directly compare daptomycin against vancomycin. The main goal is to see which drug leads to better overall patient outcomes, …
Matched conditions: STAPHYLOCOCCUS AUREUS ENDOCARDITIS
Phase: PHASE4 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Heart valve infection study questions standard antibiotic
Disease control Recruiting nowThis study aims to find out if doctors can safely skip the antibiotic rifampin when treating serious Staph infections on artificial heart valves. It will compare outcomes for 330 patients who either receive or do not receive rifampin alongside standard treatment. The goal is to s…
Matched conditions: STAPHYLOCOCCUS AUREUS ENDOCARDITIS
Phase: PHASE3 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Two-Drug attack on deadly blood infection enters human trials
Disease control Recruiting nowThis study is testing if adding a second antibiotic called ertapenem to the standard treatment (cefazolin) works better for adults with a serious Staphylococcus aureus blood infection. The goal is to help patients clear the infection from their blood faster, which could improve s…
Matched conditions: STAPHYLOCOCCUS AUREUS ENDOCARDITIS
Phase: PHASE2 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Blood thinner doubles as infection fighter in major trial
Disease control Recruiting nowThis study is for people with a serious Staph blood infection who are already taking certain blood thinners. It will test if switching their medication to dabigatran, a blood thinner that may also fight the bacteria, leads to better recovery. Researchers will compare outcomes lik…
Matched conditions: STAPHYLOCOCCUS AUREUS ENDOCARDITIS
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Heart pill may fight deadly blood infection
Disease control Recruiting nowThis study is testing if switching from aspirin to a different blood thinner, clopidogrel, helps patients recover better from serious Staphylococcus aureus (Staph) bloodstream infections. It will enroll 300 patients who are already taking aspirin to prevent heart problems. Resear…
Matched conditions: STAPHYLOCOCCUS AUREUS ENDOCARDITIS
Phase: PHASE4 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC